DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.
暂无分享,去创建一个
Dan Grandér | David Oscier | J. Lovén | D. Grandér | D. Oscier | Mikael Lerner | M. Harada | J. Castro | Z. Davis | M. Henriksson | O. Sangfelt | M. Corcoran | Juan Castro | Zadie Davis | Marie Henriksson | Jakob Lovén | Martin M Corcoran | Olle Sangfelt | Mikael Lerner | Masako Harada | Jakob Lovén
[1] C. Larsson,et al. DLEU2 encodes an antisense RNA for the putative bicistronic RFP2/LEU5 gene in humans and mouse , 2004, Genes, chromosomes & cancer.
[2] C. Croce,et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[3] Shuang Huang,et al. Involvement of MicroRNA in AU-Rich Element-Mediated mRNA Instability , 2005, Cell.
[4] Reuven Agami,et al. Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation , 2007 .
[5] Mauro Biffoni,et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.
[6] A. Siegbahn,et al. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. , 1994, Leukemia.
[7] Haoming Zhang,et al. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes , 2008, Nucleic acids research.
[8] A. Freeman,et al. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse. , 2007, Cancer genetics and cytogenetics.
[9] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[10] F. Saggioro,et al. MicroRNAs differentially expressed in ACTH-secreting pituitary tumors. , 2009, The Journal of clinical endocrinology and metabolism.
[11] S. Reed,et al. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line , 2001, Nature.
[12] R. Natarajan,et al. Distinct Roles of Heterogeneous Nuclear Ribonuclear Protein K and microRNA-16 in Cyclooxygenase-2 RNA Stability Induced by S100b, a Ligand of the Receptor for Advanced Glycation End Products*♦ , 2008, Journal of Biological Chemistry.
[13] Richard A. Ashmun,et al. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle , 1991, Cell.
[14] A. Klein-Szanto,et al. Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex , 2006 .
[15] M. Tyers,et al. Proteolysis and the cell cycle: with this RING I do thee destroy. , 2000, Current opinion in genetics & development.
[16] S. Reed,et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. , 2007, Cancer research.
[17] P. Farnham,et al. c-Myc target gene specificity is determined by a post-DNAbinding mechanism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Prats,et al. The VEGF IRESes are differentially susceptible to translation inhibition by miR-16. , 2009, RNA.
[19] P. Hinds,et al. Cyclins and cdks in development and cancer: a perspective , 2005, Oncogene.
[20] Eduardo Sontag,et al. Transcriptional control of human p53-regulated genes , 2008, Nature Reviews Molecular Cell Biology.
[21] Leonard D. Goldstein,et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.
[22] B. Frey,et al. Using expression profiling data to identify human microRNA targets , 2007, Nature Methods.
[23] J. Schelter,et al. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster , 2008, Cancer biology & therapy.
[24] B. Kempkes,et al. Cell cycle activation by c‐myc in a Burkitt lymphoma model cell line , 2000, International journal of cancer.
[25] W. Ansorge,et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 , 1999, The EMBO journal.
[26] A. Gerber,et al. Post-transcriptional gene regulation: From genome-wide studies to principles , 2007, Cellular and Molecular Life Sciences.
[27] S. Reed,et al. Activation of cyclin E/CDK2 is coupled to site‐specific autophosphorylation and ubiquitin‐dependent degradation of cyclin E. , 1996, The EMBO journal.
[28] M. Kaminski,et al. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. , 2008, Cancer research.
[29] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Bartek,et al. Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer. , 1995, Cancer letters.
[31] E. Campo,et al. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics , 2007, Nature Reviews Cancer.
[32] H. Döhner,et al. Genetic features of B-cell chronic lymphocytic leukemia. , 2000, Reviews in clinical and experimental hematology.
[33] A. Cuneo,et al. Secondary Chromosome Changes in Mantle Cell Lymphoma: Cytogenetic and Fluorescence in situ Hybridization Studies , 2001, Leukemia & lymphoma.
[34] F. Pontén,et al. The RBCC gene RFP2 (Leu5) encodes a novel transmembrane E3 ubiquitin ligase involved in ERAD. , 2007, Molecular biology of the cell.
[35] L. Lim,et al. Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression , 2007, Molecular and Cellular Biology.
[36] G. Maira,et al. Regulation of the p 27 Kip 1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation , 2007 .
[37] Liu Hong,et al. miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells , 2008, International journal of cancer.
[38] G. Gerrard,et al. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results , 2003, British journal of haematology.
[39] V. Kim,et al. Processing of intronic microRNAs , 2007, The EMBO journal.
[40] M. Soares,et al. Cloning and gene mapping of the chromosome 13q14 region deleted in chronic lymphocytic leukemia. , 1997, Genomics.
[41] E. Zabarovsky,et al. Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14. , 2000, Genomics.
[42] Yu Liang,et al. BMC Genomics , 2007 .
[43] N. Bhattacharya,et al. Chronic lymphocytic leukemia and 13q14: miRs and more , 2009, Leukemia & lymphoma.
[44] Peggy J. Farnham,et al. Analysis of Myc Bound Loci Identified by CpG Island Arrays Shows that Max Is Essential for Myc-Dependent Repression , 2003, Current Biology.
[45] K. Uzawa,et al. Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis , 1998, International journal of cancer.
[46] L. Lim,et al. MicroRNAs in the miR-106b Family Regulate p21/CDKN1A and Promote Cell Cycle Progression , 2008, Molecular and Cellular Biology.
[47] E. Zabarovsky,et al. Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia , 1997, Oncogene.
[48] S. Reed,et al. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover , 2003, Nature Reviews Molecular Cell Biology.
[49] A. Klein-Szanto,et al. Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex. , 2006, Molecular cell.
[50] William A Robinson,et al. Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma. , 2008, Blood.
[51] A. Freeman,et al. Allelic imbalance at 13q14.2∼q14.3 in localized prostate cancer is associated with early biochemical relapse , 2007 .
[52] Tsung-Cheng Chang,et al. Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.
[53] Dustin E. Schones,et al. High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.
[54] Giovanni Vanni Frajese,et al. miR-221 and miR-222 Expression Affects the Proliferation Potential of Human Prostate Carcinoma Cell Lines by Targeting p27Kip1* , 2007, Journal of Biological Chemistry.
[55] G. Ott,et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. , 2004, Blood.